S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80

Sartorius Stedim Biotech Stock Forecast, Price & News

-6.10 (-2.01%)
(As of 06/29/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
47,681 shs
Average Volume
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

DIM Stock Forecast (MarketRank)

Overall MarketRank

1.25 out of 5 stars

Analyst Opinion: 2.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
Sartorius Stedim Biotech logo

About Sartorius Stedim Biotech (EPA:DIM)

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

DIM Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Medical Devices
Year Founded

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
0 Analysts


Pretax Margin


Sales & Book Value

Annual Sales


Free Float
Not Optionable

Sartorius Stedim Biotech Frequently Asked Questions

What is Sartorius Stedim Biotech's stock price forecast for 2022?

0 brokerages have issued 1 year target prices for Sartorius Stedim Biotech's stock. Their DIM stock forecasts range from €454.00 to €454.00. On average, they expect Sartorius Stedim Biotech's stock price to reach €454.00 in the next year. This suggests a possible upside of 52.7% from the stock's current price.
View analysts' price targets for Sartorius Stedim Biotech
or view top-rated stocks among Wall Street analysts.

How has Sartorius Stedim Biotech's stock performed in 2022?

Sartorius Stedim Biotech's stock was trading at €482.40 at the beginning of the year. Since then, DIM shares have decreased by 38.3% and is now trading at €297.40.
View the best growth stocks for 2022 here

Who are Sartorius Stedim Biotech's key executives?

Sartorius Stedim Biotech's management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman & CEO (Age 57, Pay $891k)
  • Mr. Heiko Imöhl, VP of Group Financing & Investor Relations
  • Ms. Petra Kirchhoff, Head of Corp. Communications & IR (Age 53)
  • Mr. John Gerard Mackay, Exec. VP of Marketing, Sales & Services for Lab Products and Services Division (Age 60)
  • Benedikt Orzelek, Head of Investor Relations
  • Olivier Guitard, Head of Controlling BPS

What other stocks do shareholders of Sartorius Stedim Biotech own?

What is Sartorius Stedim Biotech's stock symbol?

Sartorius Stedim Biotech trades on the EPA under the ticker symbol "DIM."

What is Sartorius Stedim Biotech's stock price today?

One share of DIM stock can currently be purchased for approximately €297.40.

How many employees does Sartorius Stedim Biotech have?

Sartorius Stedim Biotech employs 10,409 workers across the globe.

How can I contact Sartorius Stedim Biotech?

The official website for Sartorius Stedim Biotech is www.sartorius.com. The company can be reached via phone at 33 4 42 84 56 00.

This page (EPA:DIM) was last updated on 6/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.